246
Participants
Start Date
Not specified
Study Completion Date
January 31, 1999
Indinavir sulfate
Ritonavir
Ethambutol hydrochloride
Clarithromycin
Rifabutin
Beth Israel Med. Ctr. (Mt. Sinai), New York
NY Univ. HIV/AIDS CRS, New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Johns Hopkins Adult AIDS CRS, Baltimore
Unc Aids Crs, Chapel Hill
The Ponce de Leon Ctr. CRS, Atlanta
Alabama Therapeutics CRS, Birmingham
The Ohio State Univ. AIDS CRS, Columbus
Univ. of Cincinnati CRS, Cincinnati
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis
Methodist Hosp. of Indiana, Indianapolis
Hennepin County Med. Ctr., Div. of Infectious Diseases, Minneapolis
University of Minnesota, ACTU, Minneapolis
Northwestern University CRS, Chicago
Cook County Hosp. CORE Ctr., Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Weiss Memorial Hosp., Chicago
Washington U CRS, St Louis
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
University of Colorado Hospital CRS, Aurora
USC CRS, Los Angeles
UCLA CARE Center CRS, Los Angeles
Harbor-UCLA Med. Ctr. CRS, Torrance
Ucsd, Avrc Crs, San Diego
Ucsf Aids Crs, San Francisco
Queens Med. Ctr., Honolulu
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
University of Washington AIDS CRS, Seattle
Bmc Actg Crs, Boston
Beth Israel Deaconess - East Campus A0102 CRS, Boston
Mbeya Med. Research Program, Mbeya Referral Hosp. CRS, Mbeya
National Institute of Allergy and Infectious Diseases (NIAID)
NIH